AstraZeneca Investor Day Presentation Deck
June 2022, 43 slides
  1. AstraZeneca
  2. Related Decks
  3. Investor Day Presentation Decks
meet management society of clinical oncology cancers symposium | AstraZeneca
forward looking statements | AstraZeneca
| AstraZeneca
speakers | AstraZeneca
agenda | AstraZeneca
oncology | AstraZeneca
| AstraZeneca
the story so far on | AstraZeneca
best in class her directed antibody drug conjugate | AstraZeneca
has demonstrated efficacy across multiple cancer types | AstraZeneca
potential for activity across spectrum of her expression | AstraZeneca
results from the phase i trial paved the way for in her low breast cancer | AstraZeneca
phase destiny breast trial breast | AstraZeneca
destiny breast trial design | AstraZeneca
characteristics | AstraZeneca
prior therapies | AstraZeneca
progression free survival by blinded independent central review | AstraZeneca
overall survival by blinded independent central review | AstraZeneca
subgroup analysis in cohort | AstraZeneca
safety and tolerability | AstraZeneca
destiny breast establishes as the new standard of care in her low breast | AstraZeneca
destiny breast redefining cancer treatment breast | AstraZeneca
continuing to transform breast cancer | AstraZeneca
her low breast cancer visible but | AstraZeneca
transforms the treatment paradigm | AstraZeneca
establishing a new standard of care | AstraZeneca
what next for in oncology | AstraZeneca
could address triple negative patients | AstraZeneca
positioned to address the full spectrum of breast cancer | AstraZeneca
initial opportunities | AstraZeneca
oral potent and selective pan inhibitor | AstraZeneca
targeting protein | AstraZeneca
a novel | AstraZeneca
in advanced renal cell carcinoma | AstraZeneca
best in class inhibitor | AstraZeneca
question and answer session | AstraZeneca
panel | AstraZeneca
appendix | AstraZeneca
destiny breast | AstraZeneca
confirmed objective response rate | AstraZeneca
best change in target lesions all patients | AstraZeneca
investor relations | AstraZeneca
| AstraZeneca
See More
AstraZeneca
Investor Day Presentation Decks
Drug Manufacturers—General Decks
Healthcare Decks
Explore Topics
Cancer
Oncology
Metastatic
Recent decks by AstraZeneca
Results
February 2025
Results
November 2024
Results
November 2024
Investor Event
September 2024
See all presentations by AstraZeneca (31 decks)
Related decks
Alkermes
Investor Presentation
October 2023
BioNTech
Results
August 2021
BioNTech
Results
May 2021
Nuvectis Pharma
Investor Presentation
December 2023
Nuvalent
Investor Presentation
October 2022
BioNTech
Results
March 2021
Nuvectis Pharma
Investor Presentation
July 2023
BioNTech
Results
November 2020
Recent decks by AstraZeneca
See all presentations (31 decks)
Results
February 2025
Results
November 2024
Results
November 2024
Investor Event
September 2024
Alkermes
Investor Presentation
October 2023
BioNTech
Results
August 2021
BioNTech
Results
May 2021
Nuvectis Pharma
Investor Presentation
December 2023
Nuvalent
Investor Presentation
October 2022
BioNTech
Results
March 2021
Nuvectis Pharma
Investor Presentation
July 2023
BioNTech
Results
November 2020
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights